Cargando…
A pilot study investigating the role of (18)F‐FDG‐PET in the early identification of chemoradiotherapy response in anal cancer
INTRODUCTION: Anal cancer (AC) is (18)F‐FDG‐PET avid and has been used to evaluate treatment response several months after chemoradiotherapy. This pilot study aimed to assess the utility of semi‐automated contouring methods and quantitative measures of treatment response using (18)F‐FDG‐PET imaging...
Autores principales: | Smith, Drew, Joon, Daryl Lim, Knight, Kellie, Sim, Jenny, Schneider, Michal, Lau, Eddie, Foroudi, Farshad, Khoo, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714497/ https://www.ncbi.nlm.nih.gov/pubmed/35906833 http://dx.doi.org/10.1002/jmrs.611 |
Ejemplares similares
-
FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
por: Day, F L, et al.
Publicado: (2011) -
Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial (18)F-FDG PET/CT
por: Wang, Jiahui, et al.
Publicado: (2019) -
Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013) -
PSMA-PET Detection of Unusual Metastases in Castrate-Sensitive Prostate Carcinoma
por: Harris, Nathanial, et al.
Publicado: (2023) -
(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)